摘要
["Aim To investigate the cytotoxicity of bioaggregate (BA; Innovative Bioceramix, Vancouver, BC, Canada) to human periodontal ligament (PDL) fibroblasts and its effect on differentiation of human PDL fibroblasts and to compare its performance to that of mineral trioxide aggregate (MTA; Dentsply, Tulsa, OK, USA).","Methodology Cytotoxicity was assessed by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay on days 1, 2, and 3 after incubation with BA or MTA. The influence of BA and MTA on differentiation of human PDL fibroblasts on days 3, 5, and 7 was evaluated by gene expression of alkaline phosphatase (ALP) and collagen type I (COLI) via quantitative real-time polymerase chain reaction (PCR). The data were analysed by one-way analysis of variance followed by Tukey's test.","Results Cell numbers in the BA group were similar to that of the control group throughout the culture period, whereas MTA suppressed the proliferation of fibroblasts. ALP expression was significantly increased in the BA group on day 7, whilst it was enhanced by MTA on day 3. Gene expression of COLI was induced by both BA and MTA compared to the control group.","Conclusions Bioaggregate was nontoxic to human PDL fibroblasts and appeared to induce the differentiation of human PDL fibroblasts."]
| 源语言 | 英语 |
|---|---|
| 页(从-至) | 1116-1121 |
| 页数 | 6 |
| 期刊 | International Endodontic Journal |
| 卷 | 43 |
| 期 | 12 |
| DOI | |
| 出版状态 | 已出版 - 12月 2010 |
基金资助
This study was supported by a grant (no.30872882) from the National Natural Scientific Foundation of China, a grant (no.30772417) from the National Natural Scientific Foundation of China, and a grant (no.304131587) from China Hubei Provincial Science & Technology Department.
关键词
- bioaggregate
- cytotoxicity
- differentiation
- periodontal ligament fibroblasts
- root-end filling material
收录
- Scopus
- SCIE
学术指纹
探究 'Effect of bioaggregate on differentiation of human periodontal ligament fibroblasts' 的科研主题。它们共同构成独一无二的学术指纹。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver